Stool microscopy 18 year male 7.8 gm% Hemoglobin. Microcytic hypochrmic anemia mostly IDA.
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
The microscopy image and clinical context are clear. Here is a comprehensive analysis:
Stool Microscopy Interpretation
What the Image Shows
The microscopic field reveals hookworm larvae (rhabditiform/filariform larvae) — the elongated, translucent, worm-like structures with a characteristic undulating morphology visible in the center of the field. The upper portion also shows what appear to be plant cells/debris (the clustered polygonal structures, likely dietary artifact).
This appearance of larvae in stool (rather than just eggs) occurs when a fresh stool sample is left at room temperature before examination, allowing any hookworm eggs present to hatch.
Clinical Correlation — This Fits Perfectly
| Feature | This Patient |
|---|---|
| Age / Sex | 18-year-old male |
| Hemoglobin | 7.8 g/dL (moderate anemia) |
| Blood picture | Microcytic hypochromic — IDA |
| Stool | Hookworm larvae positive |
Hookworm infection is the most likely cause of his iron deficiency anemia.
This is a classic and well-recognised association. Hookworms (Necator americanus or Ancylostoma duodenale) attach to the small intestinal mucosa and cause chronic blood loss. Iron deficiency results when this intestinal blood loss exceeds the host's nutritional iron reserves, producing the characteristic hypochromic microcytic anemia seen here.
"Hypochromic microcytic anemia, occasionally with eosinophilia or hypoalbuminemia, is characteristic of hookworm disease." — Harrison's Principles of Internal Medicine 22E
Laboratory Diagnosis
- Eggs: Oval, thin-shelled, 55–75 μm × 35–40 μm on fresh stool wet mount
- Larvae: Seen (as in this image) when stool is left at room temperature before fixation — rhabditiform larvae hatch from eggs
- Important: Hookworm rhabditiform larvae must be differentiated from Strongyloides stercoralis larvae (S. stercoralis has a shorter buccal cavity and a notched tail in filariform stage)
- Eggs of N. americanus and A. duodenale are indistinguishable by light microscopy
"In a stool sample that is not fresh, hookworm eggs may have hatched to release rhabditiform larvae, which must be differentiated from those of S. stercoralis." — Harrison's Principles of Internal Medicine 22E
Management
1. Deworming (anthelmintic therapy)
- Albendazole 400 mg once daily × 3 days (preferred)
- Mebendazole 500 mg once OR 100 mg twice daily × 3 days
Note: There is growing concern about reduced benzimidazole efficacy against human hookworms.
2. Iron replacement
- Oral iron supplementation (ferrous sulfate 200 mg TDS) — continue for 3 months after Hb normalises to replenish stores
- For Hb 7.8 g/dL, oral iron is adequate; parenteral iron only if malabsorption or non-compliance
3. Nutritional support
- Ensure adequate dietary protein and iron intake
- Severe infections may cause hypoproteinemia alongside anemia
4. Follow-up
- Repeat stool examination after treatment to confirm clearance
- Recheck Hb at 4–6 weeks
Summary
This 18-year-old male has hookworm-associated iron deficiency anemia — the stool microscopy confirms the etiology of what was clinically presumed to be dietary/idiopathic IDA. Treating only the anemia without deworming would lead to relapse. The priority is albendazole + iron supplementation with follow-up stool exam.
Treatment with treating anemia
Finding Sources
Finding Sources
Reading File
Reading File
Here is the complete treatment plan for this patient — addressing both the hookworm infestation and the iron deficiency anemia:
Treatment Plan: Hookworm-Associated IDA
Step 1 — Eradicate the Hookworm (Remove the Cause)
Treating the anemia without deworming guarantees relapse.
| Drug | Dose | Duration |
|---|---|---|
| Albendazole (first-line) | 400 mg orally once daily | 3 days |
| Mebendazole (alternative) | 500 mg orally once or 100 mg BD | 3 days |
| Pyrantel pamoate (alternative) | 11 mg/kg orally | Single dose |
"Three daily oral doses of albendazole 400 mg is the recommended treatment… Iron supplementation is recommended in patients with significant or symptomatic anemia." — Goldman-Cecil Medicine
- Take albendazole with a fatty meal to improve absorption
- Confirm clearance with repeat stool exam 2–4 weeks post-treatment
Step 2 — Correct the Iron Deficiency Anemia
This patient (Hb 7.8 g/dL) has moderate IDA — oral iron is sufficient.
Preferred: Oral Iron Therapy
| Preparation | Tablet Size | Elemental Iron/Tablet | Dose |
|---|---|---|---|
| Ferrous sulfate (preferred) | 325 mg | 65 mg | 2–3 tablets/day |
| Ferrous fumarate | 325 mg | 106 mg | 2 tablets/day |
| Ferrous gluconate | 325 mg | 36 mg | 3–4 tablets/day |
Target: 200–400 mg of elemental iron per day for fastest correction.
"Oral iron corrects the anemia just as rapidly and completely as parenteral iron in most cases if iron absorption from the GI tract is normal." — Katzung's Basic & Clinical Pharmacology, 16th Ed.
Duration: Continue oral iron for 3–6 months after Hb normalises to fully replenish iron stores (not just correct anemia).
Tips to Improve Adherence & Absorption:
- Take on an empty stomach (if tolerated) — maximises absorption
- Take with vitamin C (e.g., a glass of orange juice) — enhances ferrous iron absorption
- Avoid taking with milk, tea, antacids, or calcium supplements (reduce absorption)
- If GI side effects (nausea, constipation, cramps) are problematic:
- Take with food (slight reduction in absorption but much better tolerated)
- Switch to a different ferrous salt
- Consider alternate-day dosing — emerging evidence shows it reduces side effects and may improve net absorption due to hepcidin cycling
When to Use Parenteral Iron (IV):
Reserve for this patient only if:
- Cannot tolerate oral iron despite adjustments
- Malabsorption from concurrent gut pathology
- Needs rapid repletion (though not needed here)
Step 3 — Dietary Advice
- Increase haem iron sources: red meat, chicken, fish
- Increase non-haem iron: lentils, spinach, fortified cereals — combined with vitamin C
- Avoid iron-blocking foods around dose times: tea, coffee, dairy
Step 4 — Monitoring
| Time | Action |
|---|---|
| 2 weeks | Reticulocyte count should rise (reticulocyte response confirms iron replenishment) |
| 4–6 weeks | Recheck Hb — expect rise of ~1–2 g/dL per week with compliance |
| 2–4 weeks post-deworming | Repeat stool examination for clearance |
| 3 months | Hb, serum ferritin — confirm stores replenished before stopping iron |
Summary
| Priority | Action |
|---|---|
| 1st | Albendazole 400 mg OD × 3 days |
| 2nd | Ferrous sulfate 325 mg BD–TDS × 3–6 months |
| 3rd | Vitamin C with each dose |
| 4th | Dietary counselling |
| 5th | Follow-up Hb + stool exam |
The cornerstone principle: treat the worm, then replenish the iron — both are mandatory for lasting cure.
Ferrous carboxylate maltose dosage and duration
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Here is a focused guide on Ferric Carboxymaltose (FCM) — noting that the commonly used name "ferrous carboxylate maltose" refers to this same intravenous iron compound (ferric carboxymaltose, trade name: Ferinject / Injectafer).
Ferric Carboxymaltose (IV Iron) — Dosage & Duration
What It Is
A third-generation IV iron preparation. Iron content: 50 mg/mL. It delivers large doses rapidly without requiring a test dose.
Dose Calculation for This Patient
Ganzoni Formula (Total Iron Deficit):
Total iron (mg) = Body weight (kg) × (Target Hb − Actual Hb) × 2.4 + 500
For this 18-year-old male (assume ~60 kg, Hb 7.8 g/dL, target Hb 13 g/dL):
= 60 × (13 − 7.8) × 2.4 + 500 = 60 × 5.2 × 2.4 + 500 = 748.8 + 500 = ~1250 mg
However, as Goldman-Cecil notes, formulas can be unreliable — the pragmatic standard approach is a 1000 mg replacement dose, with ferritin re-checked at 2–4 weeks to determine if a second dose is needed.
Standard Dosing Regimen
| Parameter | Detail |
|---|---|
| Concentration | 50 mg/mL |
| Maximum single dose | 750–1000 mg |
| Administration | IV infusion over 15 minutes |
| Typical course | Two doses of 750 mg, one week apart |
| Total course dose | 1000–1500 mg (depending on deficit) |
"Ferric carboxymaltose — given as two 750 mg doses a week apart" — Goldman-Cecil Medicine
"Iron carboxymaltose: 50 mg/mL, maximum single dose 750–1000 mg, over 15 min infusion" — Harrison's Principles of Internal Medicine 22E
Practical Administration
- Dilute in 100–250 mL of 0.9% NaCl (do NOT use dextrose)
- Infuse over 15 minutes minimum
- No test dose required (unlike iron dextran)
- Observe patient for 30 minutes post-infusion for reactions
- Do NOT give with diphenhydramine as premedication — it can worsen reactions
Important Adverse Effect: Hypophosphatemia
- ~75% of patients develop serum phosphorus < 2.0 mg/dL after FCM
- Usually transient, but can be symptomatic (muscle weakness, bone pain) especially with repeated dosing
- Check serum phosphate before and after infusion
- This is a distinguishing disadvantage of FCM vs. iron derisomaltose
Monitoring After FCM
| Timepoint | Action |
|---|---|
| 30 min post-infusion | Observe for infusion reactions |
| 2–4 weeks | Check serum ferritin — if < 50 ng/mL, give a second dose |
| 4–6 weeks | Check Hb — expect significant rise |
| 3–4 months | Recheck ferritin; repeat infusion if < 50 ng/mL |
When to Use IV FCM (vs. Oral Iron)
For this patient specifically, oral ferrous sulfate is adequate (Hb 7.8 g/dL, no malabsorption). Use FCM if:
- Cannot tolerate oral iron despite dose adjustment
- Oral iron fails (Hb not rising after 2 weeks)
- Concurrent bowel disease affecting absorption
- Rapid repletion needed before surgery
- Patient compliance is a concern
"Formulas that calculate the total iron deficit tend to be unreliable, so the most pragmatic approach is to use a 1000 mg replacement dose. Patients with severe IDA may have deficits exceeding 1 g, so ferritin should be checked 2–4 weeks after infusion." — Goldman-Cecil Medicine
This is a shared conversation. Sign in to Orris to start your own chat.